Wells Fargo lowered the price target for the The Clorox Company (NYSE:CLX) stock to ‘an Underweight’. The rating was released on February 04, 2023, according to finviz. We previously noted in another research note published on February 04, 2023 by UBS that reiterated the stock to a Sell with a price target of $148 for CLX stock. The research report from Morgan Stanley has reiterated the stock to Underweight, with a price target set at $140. The stock was reiterated by JP Morgan, who disclosed in a research note on February 04, 2023, to Underweight and set the price objective to $137.